Dose-escalation study of three-dimensional conformal thoracic radiotherapy with concurrent S-1 and cisplatin for inoperable stage III non-small-cell lung cancer

Clinical Lung Cancer

Volumn 14, Issue 4, 2013, Pages 440-445

  Harada, Hideyuki ^a   Nishio, Makoto ^b   Murakami, Haruyasu ^a   Ohyanagi, Fumiyoshi ^b   Kozuka, Takuyo ^b   Ishikura, Satoshi ^c   Naito, Tateaki ^a   Kaira, Kyoichi ^a   Takahashi, Toshiaki ^a   Horiike, Atsushi ^b   Nishimura, Tetsuo ^a   Yamamoto, Nobuyuki ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

^b CANCER INSTITUTE HOSPITAL   (Japan)

^c JUNTENDO UNIVERSITY   (Japan)

Author keywords

Chemotherapy; Dose escalation; Non small cell lung cancer; Radiotherapy

Indexed keywords

CISPLATIN; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR;

ADULT; AGED; ANEMIA; ANGINA PECTORIS; ANOREXIA; ARTICLE; BODY SURFACE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CHEMORADIOTHERAPY; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; CONSOLIDATION CHEMOTHERAPY; CONSTRICTIVE PERICARDITIS; DIARRHEA; DISTANT METASTASIS FREE SURVIVAL; DRUG DOSE REDUCTION; DRUG EFFICACY; ESOPHAGITIS; FEASIBILITY STUDY; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HUMAN; INFECTION; INOPERABLE CANCER; LARGE CELL CARCINOMA; LEUKOPENIA; LOCAL RECURRENCE FREE SURVIVAL; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; MUCOSA INFLAMMATION; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; OPEN STUDY; PHASE 1 CLINICAL TRIAL; PNEUMONIA; PNEUMOTHORAX; RADIATION DOSE; RADIATION DOSE ESCALATION; THROMBOCYTOPENIA;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; DOSE FRACTIONATION; DRUG COMBINATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGING, THREE-DIMENSIONAL; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OXONIC ACID; PROGNOSIS; RADIOTHERAPY, CONFORMAL; SURVIVAL RATE; TEGAFUR;

EID: 84878790239     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2013.01.003     Document Type: Article

References (22)

1. T. Le Chevalier, R. Arriagada, E. Quoix Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients J Natl Cancer Inst 83 1991 417 423
2. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials Non-small cell Lung Cancer Collaborative Group BMJ 311 1995 899 909
3. B. Jeremic, Y. Shibamoto, L. Acimovic Randomized trial of hyperfractionated radiation therapy with or without on current chemotherapy for stage III non-small-cell lung cancer J Clin Oncol 13 1995 452 458
4. K. Furuse, M. Fukuoka, M. Kawahara Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer J Clin Oncol 17 1999 2962 2969
5. W.J. Curran Jr, R. Paulus, C.J. Langer Sequential vs, concurrent chemoradiation for stage III non-small-cell lung cancer: randomized phase III trial RTOG 9410 J Natl Cancer Inst 103 2011 1452 1460
6. P.A. Bunn Jr, K. Kelly New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions Clin Cancer Res 4 1998 1087 1100
7. P.C. Hoffman, A.M. Mauer, E.E. Vokes Lung cancer Lancet 355 2000 479 485
8. Y. Chen, P. Okunieff Radiation and third-generation chemotherapy Hematol Oncol Clin North Am 18 2004 55 80
9. N. Yamamoto, K. Nakagawa, Y. Nishimura Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105 J Clin Oncol 28 2010 3739 3745
10. A. Brade, A. Bezjak, R. MacRae Phase I trial of radiation with concurrent and consolidation pemetrexed and cisplatin in patients with unresectable stage IIIA/IIIB non-small-cell lung cancer Int J Radiat Oncol Biol Phys 79 2011 1395 1401
11. F. Cardenal, M.D. Arnaiz, T. Morán Phase I study of concurrent chemoradiation with pemetrexed and cisplatin followed by consolidation pemetrexed for patients with unresectable stage III non-small cell lung cancer Lung Cancer 74 2011 69 74
12. S. Niho, K. Kubota, K. Nihei Dose-escalation study of thoracic radiotherapy in combination with pemetrexed plus cisplatin followed by pemetrexed consolidation therapy in Japanese patients with locally advanced nonsquamous non-small-cell lung cancer Clin Lung Cancer 14 2013 62 69
13. K. Kaira, N. Sunaga, N. Yanagitani Phase I study of oral S-1 plus cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer Int J Radiat Oncol Biol Phys 75 2009 109 114
14. F. Ohyanagi, N. Yamamoto, A. Horiike Phase II trial of S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer Br J Cancer 101 2009 225 231
15. Y. Ichinose, T. Seto, T. Sasaki S-1 plus cisplatin with concurrent radiotherapy for locally advanced non-small cell lung cancer A multi-institutional phase II trial (West Japan Thoracic Oncology Group 3706) J Thorac Oncol 6 2011 2069 2075
16. N. Katakami, A. Gemma, H. Sakai Randomized phase III trial of S-1 plus cisplatin versus docetaxel plus cisplatin for advanced non-small-cell lung cancer (TCOG0701) J Clin Oncol 30 suppl 2012 7515a
17. S. Yuan, X. Sun, M. Li A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III non-small cell lung cancer Am J Clin Oncol 30 2007 239 244
18. J.D. Bradley, K. Bae, M.V. Graham Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117 J Clin Oncol 28 2010 2475 2480
19. M.A. Socinski, A.W. Blackstock, J.A. Bogart Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105 J Clin Oncol 26 2008 2457 2463
20. A. Sandler, C. Graham, M. Baggstrom An open-label, multicenter, three-stage, phase II study of s-1 in combination with cisplatin as first-line therapy for patients with advanced non-small cell lung cancer J Thorac Oncol 6 2011 1400 1406
21. M. Kawahara, K. Furuse, Y. Segawa Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer Br J Cancer 85 2001 939 943
22. Y. Ichinose, K. Yoshimori, H. Sakai S-1 plus cisplatin combination chemotherapy in patients with advanced non-small cell lung cancer: a multi-institutional phase II trial Clin Cancer Res 10 2004 7860 7864